EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Exploring gastric cancer genetics: A turning point in common variable immunodeficiency

Silvia Sánchez-Ramón, Jesús Fuentes-Antrás, Nicholas L Rider, Pedro Pérez-Segura, Eduardo de la Fuente-Muñoz, Miguel Fernández-Arquero, Esmeralda Neves, Rebeca Pérez de Diego, Alberto Ocaña, Kissy Guevara-Hoyer

Journal of Allergy and Clinical Immunology: Global · 2024-05 · 3 (2) · 100203

DOI: 10.1016/j.jacig.2023.100203 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Allergy and Clinical Immunology: Global, 2024-05. Verfasst von Silvia Sánchez-Ramón und 9 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Immunomonitoring and Immune-Mediated Diseases Research Unit, San Carlos Health Research Institute (IdSSC), Department of Clinical Immunology, …. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Takeda Pharmaceutical Company, Instituto de Salud Carlos III, European Social Fund Plus.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Gastric cancer (GC) stands as a prominent cause of cancer-related mortality and ranks second among the most frequently diagnosed malignancies in individuals with common variable immunodeficiency (CVID).

Objective

We sought to conduct a comprehensive, large-scale genetic analysis to explore the CVID-associated germline variant landscape within gastric adenocarcinoma samples and to seek to delineate the transcriptomic similarities between GC and CVID.

Methods

We investigated the presence of CVID-associated germline variants in 1591 GC samples and assessed their impact on tumor mutational load. The progression of GC was evaluated in patients with and without these variants. Transcriptomic similarities were explored by matching differentially expressed genes in GC to healthy gastric tissue with a CVID transcriptomic signature.

Results

CVID-associated germline variants were found in 60% of GC samples. Our analysis revealed a significant association between the presence of CVID-related genetic variants and higher tumor mutational load in GC (P < .0001); high GC mutational load seems to be linked to immunotherapy response and worse prognosis. Transcriptomic similarities unveiled key genes and pathways implicated in innate immune responses and tumorigenesis. We identified upregulated genes related to oncogene drivers, inflammation, tumor suppression, DNA repair, and downregulated immunomodulatory genes shared between GC and CVID.

Conclusions

Our findings contribute to a deeper understanding of potential molecular modulators of GC and shed light on the intricate interplay between immunodeficiency and cancer. This study underscores the clinical relevance of CVID-related variants in influencing GC progression and opens avenues for further exploration into novel therapeutic approaches.

Schlagwörter

Stichwörter der Autor:innen

CVIDGastric cancercommon variable immunodeficiencygermline variantssomatic mutation

Autor:innen und Institutionen

  • Cancer Immunomonitoring and Immune-Mediated Diseases Research Unit, San Carlos Health Research Institute (IdSSC), Department of Clinical Immunology, San Carlos University Hospital, Madrid, Spain.
  • Department of Clinical Immunology, Instituto de médicina de laboratorio (IML) and IdSSC, San Carlos University Hospital, Madrid, Spain.
  • Department of Immunology, Ophthalmology and ENT, School of Medicine, Universidad Complutense, Madrid, Spain.
  • Department of Medical Oncology, IdSSC, San Carlos University Hospital, Madrid, Spain.
  • Experimental Therapeutics and Translational Oncology Unit, Department of Medical Oncology, IdSSC, San Carlos University Hospital, and CIBERONC, Madrid, Spain.
  • Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.

Förderung

  • Takeda Pharmaceutical Company
  • Instituto de Salud Carlos III
  • European Social Fund Plus
  • Sociedad Española de Oncología Médica
  • National Institutes of Health

Zitieren

APA

Sánchez-Ramón, S., Fuentes-Antrás, J., Rider, N. L., Pérez-Segura, P., de la Fuente-Muñoz, E., Fernández-Arquero, M., Neves, E., Pérez de Diego, R., Ocaña, A., & Guevara-Hoyer, K. (2024). Exploring gastric cancer genetics: A turning point in common variable immunodeficiency. Journal of Allergy and Clinical Immunology: Global, 3(2), 100203. https://doi.org/10.1016/j.jacig.2023.100203

Vancouver

Sánchez-Ramón S, Fuentes-Antrás J, Rider NL, Pérez-Segura P, de la Fuente-Muñoz E, Fernández-Arquero M, et al. Exploring gastric cancer genetics: A turning point in common variable immunodeficiency. Journal of Allergy and Clinical Immunology: Global. 2024;3(2):100203. doi:10.1016/j.jacig.2023.100203

BibTeX
@article{SnchezRamn2024,
  author = {Sánchez-Ramón, Silvia and Fuentes-Antrás, Jesús and Rider, Nicholas L and Pérez-Segura, Pedro and de la Fuente-Muñoz, Eduardo and Fernández-Arquero, Miguel and Neves, Esmeralda and Pérez de Diego, Rebeca and Ocaña, Alberto and Guevara-Hoyer, Kissy},
  title = {Exploring gastric cancer genetics: A turning point in common variable immunodeficiency},
  journal = {Journal of Allergy and Clinical Immunology: Global},
  year = {2024},
  volume = {3},
  number = {2},
  pages = {100203},
  doi = {10.1016/j.jacig.2023.100203}
}
Kostenlos starten →